General Information
Revision date
2017-07-11
Product name
Nalidixic acid
Substance name
Nalidixic acid
Product Synonyms
1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
CAS No.
389-08-2
supplier name
Duchefa Biochemie B.V
Emergency telephone
Supplier contact information
Icons in SDS
Company Information
company name
Duchefa Biochemie B.V
e-mail address of the competent person responsible for the Safety Data Sheet
info@duchefa.nl
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334, H351, H361d
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
CLP CLASSIFICATION
Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 2 H351 Reproductive toxicity, Category 2 H361d
Hazard statements
see section 16 : H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H351 - Suspected of causing cancer. H361d - Suspected of damaging the unborn child.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP] Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS08
Signal word
Danger
Precautionary statements
P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear eye protection, face protection, protective clothing, protective gloves. P261 - Avoid breathing dust, fume, gas, mist, spray, vapours. P308+P313 - IF exposed or concerned: Get medical advice/attention. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER/doctor
2.3 Other hazards
No additional information available
